Sec Form 4 Filing - ABRAHAM WILLIAM @ CONMED CORP - 2014-09-02

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
ABRAHAM WILLIAM
2. Issuer Name and Ticker or Trading Symbol
CONMED CORP [ CNMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
EVP-Business Development
(Last) (First) (Middle)
C/O CONMED CORP, 525 FRENCH ROAD
3. Date of Earliest Transaction (MM/DD/YY)
09/02/2014
(Street)
UTICA, NY13502
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2014 M 10,000 A $ 31.4 11,486 D
Common Stock 09/02/2014 S 10,000 ( 1 ) D $ 39.7564 1,486 D
Common Stock 09/03/2014 M 2,500 A $ 19.93 3,986 D
Common Stock 09/03/2014 F 1,702 D $ 39.89 2,284 D
Common Stock 09/03/2014 M 2,500 A $ 29.92 4,784 D
Common Stock 09/03/2014 F 2,102 D $ 39.89 2,682 D
Common Stock 09/03/2014 M 2,500 A $ 26.69 5,182 D
Common Stock 09/03/2014 F 1,972 D $ 39.89 3,210 D
Common Stock 09/03/2014 M 5,000 A $ 16.46 8,210 D
Common Stock 09/03/2014 F 3,124 D $ 39.89 5,086 D
Common Stock 09/03/2014 M 4,000 A $ 19.26 9,086 D
Common Stock 09/03/2014 F 2,679 D $ 39.89 6,407 D
Common Stock 09/03/2014 M 3,000 A $ 27.63 9,407 D
Common Stock 09/03/2014 F 2,411 D $ 39.89 6,996 D
Common Stock 09/03/2014 M 2,000 A $ 26.09 8,996 D
Common Stock 09/03/2014 F 1,559 D $ 39.89 7,437 D
Common Stock 09/03/2014 M 1,000 A $ 32.93 8,437 D
Common Stock 09/03/2014 F 889 D $ 39.89 7,548 D
Common Stock 09/04/2014 S 6,062 D $ 40.1594 ( 2 ) 1,486 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options To Purchase Common Stock $ 31.4 09/02/2014 M 10,000 11/17/2005 05/17/2015 Common Stock 10,000 $ 0 0 D
Sars (Stock Appreciation Rights) $ 19.93 09/03/2014 M 2,500 ( 3 ) 05/16/2016 Common Stock 2,500 $ 0 0 D
Sars (Stock Appreciation Rights) $ 29.92 09/03/2014 M 2,500 ( 4 ) 05/17/2017 Common Stock 2,500 $ 0 0 D
Sars (Stock Appreciation Rights) $ 26.69 09/03/2014 M 2,500 ( 4 ) 06/01/2018 Common Stock 2,500 $ 0 0 D
Sars (Stock Appreciation Rights) $ 16.46 09/03/2014 M 5,000 ( 5 ) 06/01/2019 Common Stock 5,000 $ 0 0 D
Sars (Stock Appreciation Rights) $ 19.26 09/03/2014 M 4,000 ( 5 ) 06/01/2020 Common Stock 4,000 $ 0 1,000 D
Sars (Stock Appreciation Rights) $ 27.63 09/03/2014 M 3,000 ( 5 ) 06/01/2021 Common Stock 3,000 $ 0 2,000 D
Sars (Stock Appreciation Rights) $ 26.09 09/03/2014 M 2,000 ( 5 ) 06/01/2022 Common Stock 2,000 $ 0 3,000 D
Sars (Stock Appreciation Rights) $ 32.93 09/03/2014 M 1,000 ( 5 ) 06/01/2023 Common Stock 1,000 $ 0 4,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
ABRAHAM WILLIAM
C/O CONMED CORP
525 FRENCH ROAD
UTICA, NY13502
EVP-Business Development
Signatures
Daniel S. Jonas for William Abraham by Power of Attorney 09/04/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
( 3 )The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
( 4 )The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
( 5 )The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.